- Home
- AUNA vs MGTX Comparison
AUNA vs MGTX Comparison
Compare AUNA & MGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUNA
- MGTX
- Stock Information
- Founded
- AUNA 1989
- MGTX 2015
- Country
- AUNA Luxembourg
- MGTX United States
- Employees
- AUNA N/A
- MGTX N/A
- Industry
- AUNA
- MGTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AUNA
- MGTX Health Care
- Exchange
- AUNA NYSE
- MGTX Nasdaq
- Market Cap
- AUNA 484.0M
- MGTX 520.8M
- IPO Year
- AUNA 2024
- MGTX N/A
- Fundamental
- Price
- AUNA $6.31
- MGTX $6.54
- Analyst Decision
- AUNA Buy
- MGTX Strong Buy
- Analyst Count
- AUNA 1
- MGTX 2
- Target Price
- AUNA $13.50
- MGTX $24.00
- AVG Volume (30 Days)
- AUNA 62.3K
- MGTX 448.5K
- Earning Date
- AUNA 08-20-2025
- MGTX 08-11-2025
- Dividend Yield
- AUNA N/A
- MGTX N/A
- EPS Growth
- AUNA N/A
- MGTX N/A
- EPS
- AUNA 0.58
- MGTX N/A
- Revenue
- AUNA $1,187,208,994.00
- MGTX $34,508,000.00
- Revenue This Year
- AUNA $6.45
- MGTX $365.04
- Revenue Next Year
- AUNA $7.62
- MGTX $73.18
- P/E Ratio
- AUNA $10.87
- MGTX N/A
- Revenue Growth
- AUNA 7.24
- MGTX 203.23
- 52 Week Low
- AUNA $6.13
- MGTX $3.85
- 52 Week High
- AUNA $9.38
- MGTX $8.75
- Technical
- Relative Strength Index (RSI)
- AUNA N/A
- MGTX 55.29
- Support Level
- AUNA N/A
- MGTX $6.07
- Resistance Level
- AUNA N/A
- MGTX $6.80
- Average True Range (ATR)
- AUNA 0.00
- MGTX 0.35
- MACD
- AUNA 0.00
- MGTX -0.00
- Stochastic Oscillator
- AUNA 0.00
- MGTX 37.76
About AUNA AUNA S A
Auna SA is a healthcare provider. It operates hospitals and clinics in Mexico, Peru, and Colombia, and provides prepaid healthcare plans in Peru, and dental and vision plans in Mexico. Its network includes several healthcare network facilities, consisting of hospitals, outpatient, prevention, and wellness facilities. The company operates in the following segments; Oncosalud Peru and Healthcare services in Peru, Columbia and Mexico. Key revenue is generated from Peru.
About MGTX MeiraGTx Holdings plc
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.